Monday, September 28, 2015

Atezolizumab set to change refractory lung cancer treatment

Atezolizumab is set to substantially change treatment strategies for patients with refractory lung cancer, according to new research.
Posted by at

No comments:

Post a Comment

Subscribe to: Post Comments (Atom)